colforsin has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gustafsson, JK; Hansson, GC; Sjövall, H | 1 |
| Crowe, SE; Luthra, GK; Perdue, MH | 1 |
2 other study(ies) available for colforsin and Colitis Gravis
| Article | Year |
|---|---|
Ulcerative colitis patients in remission have an altered secretory capacity in the proximal colon despite macroscopically normal mucosa.
Topics: Adult; Animals; Carbachol; Cholinergic Agonists; Colforsin; Colitis, Ulcerative; Electrophysiology; Female; Humans; Intestinal Mucosa; Intestine, Large; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Middle Aged; Remission, Spontaneous; Young Adult | 2012 |
Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease.
Topics: Animals; Antibodies, Anti-Idiotypic; Colforsin; Colitis, Ulcerative; Crohn Disease; Histamine; Histamine H1 Antagonists; Humans; Immunoglobulin E; In Vitro Techniques; Intestinal Mucosa; Ion Transport; Mast Cells; Pyrilamine; Rabbits | 1997 |